Pharma in MOTION - Day 2: Technologies & Protein Analysis

Methodology. Optimization. Technology. Innovation. Operations. Networking. These are the core capabilities that ensure your lab remains at the forefront of pharmaceutical history.

Join Waters and our panel of industry experts for this special, first edition of Pharma in MOTION . Over the course of this four-day virtual event we will discuss the unique challenges our trade faces and share potential problem-solving solutions. This is your chance to connect and brainstorm with some of the brightest minds in the scientific community.

Hear from our speakers as they present how to:

• Accelerate peptide multi-attribute method (MAM) analysis through purpose-built workflows
• Increase productivity in pharmaceutical analysis using mass detection
• Use various technologies to solve your biggest pharmaceutical challenges

Day 2: Technologies

16:00 - 16:05 CEST: Welcome and Housekeeping

• Presenter: Ngan Nguyen (Senior Business Development Manager,Waters Corporation)

16:05 – 16:35 CEST: Evaluation of RADIAN ASAP in a Process Chemistry Environment

• Presenter: Stephen W. Holman, BSc (Hons), Ph.D. (AstraZeneca)

16:35 – 17:05 CEST: Increasing Lab Productivity in Pharmaceutical Analysis with Accurate Mass Detection

• Presenter: Jayne Kirk, Ph.D. – on behalf of Pharmaphysic (Product Marketing, MS Systems, Waters Corporation)

17:05 – 17:35 CEST: Advanced Usage of SFC in Pharma – Benefits of a Forgotten or Even Unknown Technique

• Presenter: Mijo Stanic (General Manager, Chromicent GmbH)

17:35 – 17:40 CEST: Closing

• Presenter: Ngan Nguyen

Day 2: Protein Analysis

16:00 – 16:15 CEST: Welcome and Housekeeping

• Presenter: Scott Berger (Sr. Biopharmaceutical Market Development Manager, Waters Corporation)

16:15 – 16:45 CEST: Streamlining and Accelerating Peptide Multi-Attribute Method (MAM) Analysis with a BioAccord MAM Workflow to Enhance Product Knowledge

• Presenter: Ying Zhang, Ph.D. (Principal Scientist, Pfizer R&D)

16:45 – 17:15 CEST: Automating an End-to-End Middle Level LC-MS Workflow for Routine Analysis of Antibody Based Therapeutics

• Presenter: Andreas Nägeli, Ph.D. (Sr. Applications Chemist, Genovis)

17:15 – 17:45 CEST: Live Panel Q&A Session

• Presenter: Scott Berger